Aimei Health Technology Co., Ltd Ordinary Share (AFJK)
Company Profile
| Dec 2023 | ||
|---|---|---|
| Total Revenue | ||
| Cost of Revenue | ||
| Gross Profit | ||
| Gross Profit Margin (%) | ||
| R&D Expense | ||
| SG&A Expense | ||
| Total Operating Expenses | ||
| Operating Income or Loss | ||
| Operating Margin (%) | ||
| Interest Expense | ||
| Total Other Income/Expenses | ||
| Income Before Tax | ||
| Income Tax Expense | ||
| Income from Continuing Ops. | ||
| Net Income | ||
| Net Profit Margin (%) | ||
| Net Income Available to Common Shareholders | ||
| Basic EPS | ||
| Diluted EPS | ||
| Basic Average Shares | ||
| Diluted Average Shares |
| Sep 2024 | Mar 2024 | Dec 2023 | ||
|---|---|---|---|---|
| Total Revenue | ||||
| Cost of Revenue | ||||
| Gross Profit | ||||
| Gross Profit Margin (%) | ||||
| R&D Expense | ||||
| SG&A Expense | ||||
| Total Operating Expenses | ||||
| Operating Income or Loss | ||||
| Operating Margin (%) | ||||
| Interest Expense | ||||
| Total Other Income/Expenses | ||||
| Income Before Tax | ||||
| Income Tax Expense | ||||
| Income from Continuing Ops. | ||||
| Net Income | ||||
| Net Profit Margin (%) | ||||
| Net Income Available to Common Shareholders | ||||
| Basic EPS | ||||
| Diluted EPS | ||||
| Basic Average Shares | ||||
| Diluted Average Shares |
| Dec 2023 | ||
|---|---|---|
| Current Assets | ||
| Cash & Cash Equivalents | ||
| Marketable Securities | ||
| Receivables | ||
| Inventories | ||
| Other Current Assets | ||
| Total Current Assets | ||
| Non-Current Assets | ||
| Marketable Securities | ||
| PPE Net | ||
| Intangibles inc. Goodwill | ||
| Other Non-Current Assets | ||
| Total Non-Current Assets | ||
| Total Assets | ||
| Current Liabilities | ||
| Accounts Payable | ||
| Deferred Revenues | ||
| Debt, Current | ||
| Accrued Liabilities | ||
| Other Current Liabilities | ||
| Total Current Liabilities | ||
| Non-Current Liabilities | ||
| Deferred Revenues | ||
| Debt, Non-Current | ||
| Other Non-Current Liabilities | ||
| Total Non-Current Liabilities | ||
| Total Liabilities | ||
| Shareholders' Equity | ||
| Common Stock | ||
| Additional Paid-In Capital | ||
| Retained Earnings | ||
| Other Shareholders' Equity | ||
| Total Shareholders' Equity | ||
| Total Liabilities & Shareholders' Equity |
| Sep 2024 | Mar 2024 | Dec 2023 | ||
|---|---|---|---|---|
| Current Assets | ||||
| Cash & Cash Equivalents | ||||
| Marketable Securities | ||||
| Receivables | ||||
| Inventories | ||||
| Other Current Assets | ||||
| Total Current Assets | ||||
| Non-Current Assets | ||||
| Marketable Securities | ||||
| PPE Net | ||||
| Intangibles inc. Goodwill | ||||
| Other Non-Current Assets | ||||
| Total Non-Current Assets | ||||
| Total Assets | ||||
| Current Liabilities | ||||
| Accounts Payable | ||||
| Deferred Revenues | ||||
| Debt, Current | ||||
| Accrued Liabilities | ||||
| Other Current Liabilities | ||||
| Total Current Liabilities | ||||
| Non-Current Liabilities | ||||
| Deferred Revenues | ||||
| Debt, Non-Current | ||||
| Other Non-Current Liabilities | ||||
| Total Non-Current Liabilities | ||||
| Total Liabilities | ||||
| Shareholders' Equity | ||||
| Common Stock | ||||
| Additional Paid-In Capital | ||||
| Retained Earnings | ||||
| Other Shareholders' Equity | ||||
| Total Shareholders' Equity | ||||
| Total Liabilities & Shareholders' Equity |
| Dec 2023 | ||
|---|---|---|
| Cash Flows from Operating Activities | ||
| Net Income | ||
| Depreciation & Amortization | ||
| Deferred Income Taxes | ||
| Stock Based Compensation | ||
| Accounts Receivable | ||
| Inventory | ||
| Accounts Payable | ||
| Deferred Revenue | ||
| Other Non-Cash | ||
| Operating Cash Flow | ||
| Cash Flows from Investing Activities | ||
| PPE Investments | ||
| Net Acquisitions | ||
| Purchase of Investments | ||
| Sale of Investments | ||
| Other Investing Activity | ||
| Investing Cash Flow | ||
| Cash Flows from Financing Activities | ||
| Debt Issued | ||
| Proceeds from Debt Repayment | ||
| Debt Repayment | ||
| Proceeds from Sale of Equity | ||
| Equity Repurchased | ||
| Dividend Paid | ||
| Other Financing Activity | ||
| Financing Cash Flow | ||
| Cash Position | ||
| Beginning Cash Position | ||
| End Cash Position | ||
| Change in Cash | ||
| Free Cash Flow | ||
| Operating Cash Flow | ||
| Capital Expenditure | ||
| Free Cash Flow |
| Sep 2024 | Mar 2024 | Dec 2023 | ||
|---|---|---|---|---|
| Cash Flows from Operating Activities | ||||
| Net Income | ||||
| Depreciation & Amortization | ||||
| Deferred Income Taxes | ||||
| Stock Based Compensation | ||||
| Accounts Receivable | ||||
| Inventory | ||||
| Accounts Payable | ||||
| Deferred Revenue | ||||
| Other Non-Cash | ||||
| Operating Cash Flow | ||||
| Cash Flows from Investing Activities | ||||
| PPE Investments | ||||
| Net Acquisitions | ||||
| Purchase of Investments | ||||
| Sale of Investments | ||||
| Other Investing Activity | ||||
| Investing Cash Flow | ||||
| Cash Flows from Financing Activities | ||||
| Debt Issued | ||||
| Proceeds from Debt Repayment | ||||
| Debt Repayment | ||||
| Proceeds from Sale of Equity | ||||
| Equity Repurchased | ||||
| Dividend Paid | ||||
| Other Financing Activity | ||||
| Financing Cash Flow | ||||
| Cash Position | ||||
| Beginning Cash Position | ||||
| End Cash Position | ||||
| Change in Cash | ||||
| Free Cash Flow | ||||
| Operating Cash Flow | ||||
| Capital Expenditure | ||||
| Free Cash Flow |